While the current study focuses on the role of Azeliragon in pancreatic cancer, the involvement of RAGE in other cancers, such as colorectal and lung cancer, suggests that Azeliragon could have broader therapeutic applications [14,47]. The gene discussed is AGER; the disease is familial pancreatic carcinoma.